DexCom Inc (DXCM) stock

DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3030% below fair value

$83.33+1.94 (+2.38%)

Close on Nov 13, 2026Market cap $31.08BP/E 32.8Yield –

DexCom statistics

104 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 11, 2027 (estimated, after the close)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $31.08B; $498.53M
Enterprise Value: $30.12B; $433.11M
PE Ratio: 32.81; 29.52
PS Ratio: 6.09; 2.94
PB Ratio: 12.26; 3.24
P/TBV Ratio: 12.83; 4.81
P/FCF Ratio: 28.30; 26.31
P/OCF Ratio: 21.97; 21.97

Enterprise valuationIndustry

EV / Sales: 5.90; 2.60
EV / EBITDA: 20.09; 18.41
EV / EBIT: 24.61; 24.14
EV / FCF: 27.42; 27.51

Share statisticsIndustry

Shares Outstanding: 373M; 43M
Shares Change (YoY): -3.91%; 3.32%
Shares Change (QoQ): -1.17%; 0.20%
Float: 371M; 37M
Shares Held by Insiders: 0.52%; 10.5%
Shares Held by Institutions: 103.7%; 60.5%

Short sellingIndustry

Short Interest: 16M; –
Short Interest Change: 1.55%; -2.57%
Short % of Float: 4.29%; 5.11%
Short % of Shares Outstanding: 4.27%; 3.98%
Days to Cover: 2.81; 3.94

Stock price statisticsIndustry

52-Week High: $92.59; –
52-Week Low: $56.72; –
20-Day Moving Average: $81.62; –
50-Day Moving Average: $84.30; –
200-Day Moving Average: $75.08; –
Average True Range (14): $2.97; –
Price Change (1 Week): 4.94%; 0.99%
Price Change (1 Month): -4.99%; -3.52%
Price Change (3 Months): -6.12%; -7.86%
Price Change (6 Months): 35.2%; -1.12%
Price Change (YTD): 25.6%; -2.92%
Price Change (1 Year): 39.8%; -1.37%
Price Change (3 Years): -17.8%; 3.24%
Price Change (5 Years): -48.4%; -50.4%
Price Change (10 Years): 384.5%; 58.9%
Average Volume (10 Days): 4M; –
Average Volume (20 Days): 5M; –
Average Volume (90 Days): 5M; –
Relative Volume: 0.67; 0.76
Relative Strength Index (14): 51.4; 46.7
Volatility (1 Year): 37.8%; 64.2%
Beta (5 Years): 1.20; 1.04

MarginsIndustry

Gross Margin: 63.4%; 55.9%
Operating Margin: 24.0%; -5.12%
Pretax Margin: 24.7%; -2.32%
Profit Margin: 19.4%; -9.29%
EBITDA Margin: 29.4%; -2.52%
FCF Margin: 21.5%; 0.65%

Returns on capitalIndustry

Return on Equity (ROE): 37.7%; -17.3%
Return on Assets (ROA): 14.4%; -12.3%
Return on Invested Capital (ROIC): 78.0%; -2.83%
Return on Capital Employed (ROCE): 30.7%; -8.13%

Financial positionIndustry

Current Ratio: 1.74; 2.49
Quick Ratio: 0.95; 1.53
Interest Coverage: 91.33; -1.63

GrowthIndustry

Revenue Growth (YoY): 13.0%; 9.42%
Net Income Growth (YoY): 37.5%; 13.4%
EPS Growth (YoY): 41.9%; 15.1%
FCF Growth (YoY): 3.43%; 7.64%
Revenue Growth (3Y CAGR): 17.0%; 7.08%
Revenue Growth (5Y CAGR): 19.3%; 11.8%
EPS Growth (3Y CAGR): 36.6%; 3.11%
EPS Growth (5Y CAGR): 9.46%; 7.64%

EfficiencyIndustry

Asset Turnover: 0.74; 0.59
Inventory Turnover: 2.72; 2.20
Revenue Per Employee: $459.86K; $331.99K
Profits Per Employee: $89.28K; -$46.47K
Employee Count: 11,100; 193
WACC: 11.1%; 9.91%

Income statement (TTM)Industry

Revenue: $5.10B; $108.17M
Gross Profit: $3.24B; $62.29M
Operating Income: $1.22B; -$3.72M
Pretax Income: $1.26B; -$1.83M
Net Income: $991.00M; -$6.19M
EBITDA: $1.50B; -$1.98M
EPS (Diluted): $2.54; -$0.11

Balance sheetIndustry

Cash & Short-Term Investments: $961.40M; $38.97M
Net Cash (Debt): $961.40M; $3.95M
Net Cash Per Share: $2.58; $0.26
Equity (Book Value): $2.54B; $63.80M
Book Value Per Share: $6.80; $3.26
Tangible Book Value: $2.42B; $11.61M
Working Capital: $1.66B; $57.32M

Cash flow (TTM)Industry

Operating Cash Flow: $1.41B; -$483.87K
Capital Expenditures: -$316.10M; -$3.94M
Free Cash Flow: $1.10B; -$238.00K
FCF Per Share: $2.94; -$0.00

Dividends and yieldsIndustry

Earnings Yield: 3.19%; -4.76%
FCF Yield: 3.53%; 0.28%
Buyback Yield: -0.08%; 0.80%
Shareholder Yield: -0.08%; 1.12%

Taxes and interestIndustry

Interest Expense: $13.40M; $5.40M
Income Tax: $271.40M; $1.55M
Effective Tax Rate: 21.5%; 18.0%

Scores and fair valueIndustry

Graham Number: $19.71; $38.11
Graham Upside: -76.3%; -56.1%
Altman Z-Score: 7.53; 2.47
Piotroski F-Score: 8; 5
Beneish M-Score: -2.67; -2.64
Lynch Fair Value: $24.03; –
Lynch Upside: -71.2%; -45.2%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	DXCM	S&P 500	Difference	DXCM per year	S&P 500 per year
1 month	-2.0%	-3.0%	+1.0 pts
3 months	-8.9%	-2.8%	−6.1 pts
Year to date	+25.6%	+11.5%	+14.1 pts
1 year	+39.5%	+13.5%	+26.1 pts
3 years	-15.3%	+77.7%	−93.0 pts	-5.4%	+21.1%
5 years	-48.4%	+72.6%	−121.1 pts	-12.4%	+11.5%
10 years	+411.4%	+308.2%	+103.2 pts	+17.7%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

16M DXCM shares were sold short on Oct 30, 2026, up 1.5% from the previous report, or 4.29% of the shares available to trade. At recent volumes it would take 2.8 days to buy them back. Over the last 20 sessions, 49.3% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	15,933,006	+1.5%	5,675,513	2.8
Oct 15, 2026	15,690,510	+11.9%	3,304,614	4.8
Sep 30, 2026	14,017,639	-18.8%	4,440,324	3.2
Sep 15, 2026	17,263,625	-2.1%	3,464,086	5.0
Aug 31, 2026	17,626,435	+6.6%	4,089,581	4.3
Aug 14, 2026	16,528,608	-5.8%	5,619,046	2.9
Jul 31, 2026	17,545,086	-5.9%	5,089,808	3.5
Jul 15, 2026	18,654,724	+3.0%	4,273,671	4.4
Jun 30, 2026	18,109,268	+6.4%	5,030,414	3.6
Jun 15, 2026	17,017,820	-2.2%	5,375,491	3.2
May 29, 2026	17,394,929	-1.0%	8,446,687	2.1
May 15, 2026	17,564,139	-4.1%	6,309,334	2.8